System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Epublish 24 citations

PubMed: 36679863 DOI: 10.3390/vaccines11010016

Combining Influenza and COVID-19 Booster Vaccination Strategy to Improve Vaccination Uptake Necessary for Managing the Health Pandemic: A Systematic Review and Meta-Analysis.

Vaccines (Basel) 11(1)

Authors: Nikolaos Tzenios, Mary E Tazanios, Mohamed Chahine

Affiliations

  • Public Health and Medical Research, Charisma University, Grace Bay TKCA 1ZZ, Turks and Caicos Islands.
  • Doctor of Health Sciences Candidate Program, MCPHS University, Boston, MA 02115, USA.
  • Harvard Medical School Postgraduate Medical Education High Impact Cancer Research 2019-2021, Boston, MA 02115, USA.
  • Clinical Research, TRG GEN+, Beirut 0000, Lebanon.
  • Biological and Chemical Technology, International Medical Institute, Kursk State Medical University, 305030 Kursk, Russia.

Abstract

Background: The uptake of COVID-19 booster vaccines has been significantly low. Therefore, it is questionable whether combining the COVID-19 booster vaccines with influenza vaccines can increase the population’s interest in taking such vaccines and manage the health pandemic effectively. Methodology: In this systematic review and meta-analysis, a synthesis of the findings and summary of a total of 30 research articles based on the topic, ‘combining influenza and COVID-19 booster vaccination strategy’ was undertaken. The research articles were identified from three databases, namely, PubMed, Cochran Library, and Google Scholar using specific keywords and inclusion criteria. However, research articles that were not peer-reviewed and not published in English were excluded from the systematic review and meta-analysis. The average risk ratio of the intervention group getting a combination of COVID-19 booster and influenza vaccines from the samples of the included studies was 0.78 with regard to a 95% CI. Such risk ratio is based on the null hypothesis of the current study that combining COVID-19 booster and influenza vaccines can increase the uptake of COVID-19 booster vaccines. On the other hand, the heterogeneity between such studies was I2 = 35%, while the statistical significance of their findings occurred at p < 0.05. The average p-value of the included research studies was p = 0.62 with the proportion of studies with significant p-values being 63.33% which is equivalent to 19 out of 30 studies. Therefore, the null hypothesis was not rejected in more than half of the studies. Results: A synthesis of the chosen research articles revealed that when influenza and COVID-19 booster vaccines are combined, there is potential for an increase in the uptake of the latter, mainly because many populations have already been accustomed to taking influenza vaccines on an annual basis. Conclusions: In this way, through such findings, medical health experts can make informed decisions to increase the population’s willingness to receive the COVID-19 booster vaccines.

MeSH

Vaccines, Vaccination, Covid-19, Odds Ratio, Influenza, Human, Influenza Vaccines, Research, Pandemics

Cited by